Delivery Order SPE2DR25D3101-SPE2DR26F6B23
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes, with a ceiling value of $6,525.08. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for completion by December 10, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for $1,052.80 to supply SPIKEVAX 2025-26 vaccine for ages 12 and up in 0.5ML syringes. This is a firm fixed-price, non-set-aside contract with a completion date of February 4, 2026, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 7, 2026, for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25mL per unit, with a ceiling value of $1,156.92. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The order is scheduled for completion by January 29, 2026, and represents a task...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 13, 2026, for $2,632.00 to supply Spikevax 2025-26 vaccine (12 years and up) in 0.5ml syringes. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Spikevax 2025-26 vaccine (6M-11Y dosage) in 0.25ML syringes. This competitively awarded, non-set-aside contract carries a ceiling value of $2,313.88 with firm fixed pricing and a completion date of November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes, valued at $14,201.30. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The contract is scheduled for completion by December 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,156.93 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML, with completion targeted for January 8, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is classified as a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,211.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5 milliliter syringes, with a firm fixed price and an ultimate completion date of February 6, 2026. This non-set-aside contract was competitively awarded on January 15, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.33 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5mL syringes. The award, issued on January 23, 2026, with an ultimate completion date of February 13, 2026, is structured as a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,987.50 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of December 10, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F6B23Delivery Order
On February 2, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $5,264.00 to Amerisourcebergen Drug Corp for SPIKEVAX 2025-26 (12Y UP) 0.5ML syringes, with final delivery due by February 24, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. The delivery order was issued under Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.99 million and extending through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., regularly supplies an extensive portfolio of prescription medications, vaccines, and medical supplies to federal agencies through competitive procurement. The DLA's pharmaceutical procurement through this IDC reflects the agency's ongoing need to maintain inventory of critical vaccines and medical supplies across military treatment facilities and veterans' healthcare programs. This delivery order for SPIKEVAX vaccine syringes represents routine replenishment of government medical stockpiles supporting the Department of Defense healthcare mission.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 2/1/26 |